![Dirk Thye](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dirk Thye
Plus aucun poste en cours
Fortune : 154 244 $ au 30/09/2026
Profil
Dr. Dirk Thye was previously employed as a CEO, Director & Chief Medical Officer by Quince Therapeutics, Inc., a Chief Executive Officer & Director by Novosteo, Inc., a President, CEO, CFO, Secretary & Director by Agenovir Corp., an Executive Chairman by Geom Therapeutics, Inc., a Chief Medical Officer by Cidara Therapeutics, Inc., a Founder by Pfluent, Inc., a Manager-Business Process by Quality Planning Corp, a Principal by Inclin, Inc., a President by Cerexa, Inc., and a Senior Vice President-Clinical Development by Peninsula Pharmaceuticals, Inc. He also served on the board at Kalyra Pharmaceuticals, Inc. He received his undergraduate degree from the University of California, Berkeley and a graduate degree from the University of California, Los Angeles.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IRULYA THERAPEUTICS INC. 0,05 % | 29/07/2026 | 4 974 ( 0,05 % ) | 154 244 $ | 30/09/2026 |
Anciens postes connus de Dirk Thye
| Sociétés | Poste | Fin |
|---|---|---|
| IRULYA THERAPEUTICS INC. | Directeur Général | 08/10/2026 |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Directeur Général | 01/05/2022 |
Geom Therapeutics, Inc.
 Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of antibiotic for MDR gram negative infections | Fondateur | 01/07/2020 |
Agenovir Corp.
 Agenovir Corp. BiotechnologyHealth Technology Engages in research and development of human therapeutics for the treatment of diseases | Directeur Général | 01/01/2018 |
| CIDARA THERAPEUTICS | Directeur Technique/Scientifique/R&D | 02/09/2016 |
Formation de Dirk Thye
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes antibiotics to treat life-threatening infections | Commercial Services |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Kalyra Pharmaceuticals, Inc.
 Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures small molecule drugs | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quality Planning Corp
 Quality Planning Corp Insurance Brokers/ServicesFinance Provides analytic methods to insurance companies for auto insurance ratings | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inclin, Inc.
 Inclin, Inc. Miscellaneous Commercial ServicesCommercial Services Operates contract research organization and provides biometrics, clinical operations, strategic consulting, medical writing, quality assurance, drug safety and medical monitoring services | Commercial Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Agenovir Corp.
Agenovir Corp. BiotechnologyHealth Technology Engages in research and development of human therapeutics for the treatment of diseases | Health Technology |
Pfluent, Inc. | |
Geom Therapeutics, Inc.
Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of antibiotic for MDR gram negative infections | Commercial Services |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Health Technology |
